Head-to-Head Comparison
Doximity vs DynaMed: Which Is Better for Physicians?
Doximity: The Professional Medical Network with AI-Powered Tools DynaMed: Evidence-Based Clinical Decision Support by EBSCO
Updated
Direct Answer
Source: Clinical AI Report, 2026
Key takeaways
- Doximity Ask is advertised as free for US healthcare professionals; DynaMed starts at $399 a year, or $475 with Dyna AI, at US store prices checked October 25, 2026.
- DynaMed gives explicit levels of evidence and grades of recommendation for its content, which about 500 clinicians update daily from 500+ journals.
- Doximity’s drug monographs come from its 2025 Pathway Medical acquisition and are still maturing; DynaMedex adds Micromedex drug information for $599 a year.
- DynaMed connects to EHRs through HL7 Infobutton and its mobile app works offline; Doximity adds Scribe, messaging and telehealth in a network-first app.
Feature Comparison
| Feature | Doximity | DynaMed |
|---|---|---|
| Rating | Doximity: Good | DynaMed: Fair |
| Category | Doximity: Medical Professional Network & AI Tools | DynaMed: Clinical Reference & Decision Support |
| Pricing | Doximity: Free (Ad-Supported) | DynaMed: From $399/year Individual |
| Founded | Doximity: 2010 | DynaMed: 2004 |
| Headquarters | Doximity: San Francisco, CA | DynaMed: Ipswich, MA |
| Evidence Citations | Doximity: Yes | DynaMed: Yes |
| AI Differential Diagnosis | Doximity: Yes | DynaMed: No |
| Drug Database | Doximity: Yes | DynaMed: Yes |
| Drug Interaction Checker | Doximity: No | DynaMed: No |
| Medical Calculators | Doximity: No | DynaMed: Yes |
| Natural Language Search | Doximity: Yes | DynaMed: Yes |
| Document & Image Upload | Doximity: Yes | DynaMed: No |
| EHR Integration | Doximity: No | DynaMed: Yes |
| Mobile App | Doximity: Yes | DynaMed: Yes |
| Built-in Dialer | Doximity: Yes | DynaMed: No |
| AI Clinical Scribe | Doximity: Yes | DynaMed: No |
| CME Credits | Doximity: Yes | DynaMed: Yes |
| Multi-Language | Doximity: No | DynaMed: No |
Strengths & Limitations
Doximity
Strengths
- +Largest physician network in the US (3M+ members, ~85% of US physicians)
- +Ask is advertised as free for U.S. healthcare professionals; confirm account eligibility
- +Pathway Medical acquisition adds 3,200+ peer-reviewed drug monographs
- +PeerCheck physician review program (10,000+ medical experts, co-chaired by Eric Topol)
- +Evidence-based clinical answers grounded in structured medical literature
- +300,000+ clinicians actively using AI tools (Q3 FY2026)
- +AI Scribe for ambient clinical documentation
- +Secure HIPAA-compliant messaging and integrated telehealth
- +100+ health system enterprise deployments
Limitations
- –AI revenue not yet commercialized — long-term AI business model unproven
- –Networking-heavy interface can be distracting for clinical use
- –Pathway integration is recent (late 2025) — clinical depth still maturing
- –Company-published preference study lacks independent peer review
- –Revenue model relies on pharmaceutical and health system advertising
- –Check current Ask availability and workflow fit for your device and institution
DynaMed
Strengths
- +Best in KLAS for Clinical Decision Support four times (2021, 2022, 2024, 2025)
- +3,400+ clinical topics with daily updates from 500+ journal surveillance
- +Explicit levels of evidence and grades of recommendation for all content
- +DynaMedex bundle integrates Micromedex drug information
- +Lower individual pricing than UpToDate ($399/year vs $579/year)
- +Dyna AI generative assistant grounded in curated evidence (launched 2024)
- +EHR integration via HL7 Infobutton and toolbar links
- +CME/MOC credit tracking built in
Limitations
- –Lower brand recognition than UpToDate among physicians
- –Fewer clinical topics than UpToDate (3,400 vs 12,000+)
- –Dyna AI is an add-on cost ($475/year vs $399/year base)
- –AI features are newer and less mature than dedicated CDS platforms
- –Shared decision-making tools (DynaMed Decisions) require separate licensing
- –No free tier for individual physicians
Key Statistics
Doximity
DynaMed
Citable Summaries
Doximity
Doximity has an editorial score of 70/100 (3.5/5), calculated from Clinical AI Report's published criteria weights. It ranks #4 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
DynaMed
DynaMed has an editorial score of 59/100 (3.0/5), calculated from Clinical AI Report's published criteria weights. It ranks #7 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
Our Assessment
In our 2026 evaluation, Doximity (ranked #4, 3.5 stars) outperforms DynaMed (ranked #7, 3 stars) in overall physician satisfaction and editorial scoring. Doximity is best suited for physicians already embedded in the Doximity ecosystem who want AI-powered clinical answers, drug reference, and documentation without switching platforms. Especially relevant for practices with enterprise Doximity contracts. Meanwhile, DynaMed is a stronger choice for physicians and institutions seeking a KLAS-recognized, evidence-graded clinical reference at a lower price point than UpToDate, with integrated drug information via Micromedex. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.